| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Clearside Biomedical, Inc. (CLSDQ) has 0 insiders with recent SEC Form 4 filings, including 3 buys and 9 sells. CLSDQ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2017 | Hatteras Venture Advisors IV Sbic, LLC | 10% Owner, May Be Part Of A 13(d) Group | Sell | 29,656 | $8.63 | $255,784.88 | -0.5% | |
| Jun 7, 2016 | Hatteras Venture Advisors IV Sbic, LLC | 10% Owner | Sell | 69 | $7.00 | $483.00 | - | |
| Jun 7, 2016 | Thorp Clay62 | Director, 10% Owner | Sell | 138 | $7.00 | $966.00 | - | |
| Jun 7, 2016 | Cagle Gerald D. | Director | Sell | 2 | $7.00 | $14.00 | - | |
| Jun 7, 2016 | Deignan Charles A.69 | Chief Financial Officer | Sell | 2 | $7.00 | $14.00 | - | |
| Jun 7, 2016 | White Daniel H. | President And CEO | Sell | 3 | $7.00 | $21.00 | - | |
| Jun 7, 2016 | Hatteras Venture Advisors Iii, LLC | 10% Owner | Sell | 69 | $7.00 | $483.00 | - | |
| Jun 7, 2016 | Hatteras Venture Advisors IV Sbic, LLC | 10% Owner | Buy | 414,286 | $7.00 | $2,900,002.00 | +24.7% | |
| Jun 7, 2016 | Thorp Clay62 | Director, 10% Owner | Buy | 785,714 | $7.00 | $5,499,998.00 | +22.6% | |
| Jun 7, 2016 | Rmi Investments S.a.r.l. | 10% Owner | Buy | 42,857 | $7.00 | $299,999.00 | +2.8% |